Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison L Naleway

Showing results (171-180 of 235) with videos related to

Pageof 24
Sort By:
Emerging Infectious Diseases|June 28, 2026
Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024Pavitra Roychoudhury, Erica Wetzler, Anna Elias-Warren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2021
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 InfectionHarmony L Tyner, Jefferey L Burgess, Lauren Grant, et al.
Nature Communications|September 26, 2025
Correlates of risk of respiratory syncytial virus disease: a prospective cohort studyCollrane Frivold, Sarah N Cox, Lea Starita, et al.
The Journal of Infectious Diseases|February 22, 2023
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron PredominanceCatherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, et al.
The Journal of Infectious Diseases|January 8, 2025
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United StatesLeora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, et al.
BMJ Open|July 14, 2023
CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey designTara M Babu, Leora R Feldstein, Sharon Saydah, et al.
Obstetrics and Gynecology|December 11, 2025
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant WomenAllison Avrich Ciesla, Victoria Lazariu, Janet A Watts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2025
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort StudyJames K Romine, Huashi Li, Melissa M Coughlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.
Pageof 24

Showing results (171-180 of 235) with videos related to

Sort By:
Pageof 24
Emerging Infectious Diseases|June 28, 2026
Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024Pavitra Roychoudhury, Erica Wetzler, Anna Elias-Warren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2021
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 InfectionHarmony L Tyner, Jefferey L Burgess, Lauren Grant, et al.
Nature Communications|September 26, 2025
Correlates of risk of respiratory syncytial virus disease: a prospective cohort studyCollrane Frivold, Sarah N Cox, Lea Starita, et al.
The Journal of Infectious Diseases|February 22, 2023
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron PredominanceCatherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, et al.
The Journal of Infectious Diseases|January 8, 2025
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United StatesLeora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, et al.
BMJ Open|July 14, 2023
CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey designTara M Babu, Leora R Feldstein, Sharon Saydah, et al.
Obstetrics and Gynecology|December 11, 2025
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant WomenAllison Avrich Ciesla, Victoria Lazariu, Janet A Watts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2025
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort StudyJames K Romine, Huashi Li, Melissa M Coughlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.
Pageof 24